Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
21,7 NOK | -3,12% |
|
-0,46% | -6,87% |
24/04 | Vistin Pharma ASA rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
24/04 | Transcript : Vistin Pharma ASA, Q1 2024 Earnings Call, Apr 24, 2024 |
Vakgebied
Aantal werknemers: 75
Verkoop per activiteit
NOK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceuticals
100,0
%
| 288 | 100,0 % | 435 | 100,0 % | +51,35% |
Verkoop per regio
NOK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Europe
77,8
%
| 196 | 68,1 % | 339 | 77,8 % | +72,91% |
Africa
15,1
%
| 37 | 13,0 % | 66 | 15,1 % | +75,29% |
Asia
6,7
%
| 20 | 6,9 % | 29 | 6,7 % | +48,11% |
North and South America
0,3
%
| 34 | 12,0 % | 2 | 0,3 % | -95,63% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-03-20 | |
Director of Finance/CFO | - | 02-03-20 | |
Eivind Egeli
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-15 |
Vegard Heggem
PRN | Corporate Officer/Principal | - | 01-06-15 |
Sabrina Berge
PRN | Corporate Officer/Principal | - | 01-06-15 |
General Counsel | - | 01-03-15 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 76 | 01-06-20 | |
Director/Board Member | 62 | 06-03-15 | |
Director/Board Member | 60 | 01-01-20 | |
Bettina Banoun
BRD | Director/Board Member | 52 | 08-05-18 |
Åse Musum
BRD | Director/Board Member | - | 01-06-15 |
Director/Board Member | - | 01-01-17 | |
Director/Board Member | - | 01-01-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 44 344 592 | 20 062 899 ( 45,24 %) | 0 | 45,24 % |
Bedrijfsgegevens
![Adres Vistin Pharma ASA(VISTN)](https://cdn.zonebourse.com/static/address/22400915.png)
Bedrijven van de groep
Naam | Categorie en sector |
---|---|
Vistin Trading AS
![]() Vistin Trading AS Finance/Rental/LeasingFinance Part of Vistin Pharma ASA, Vistin Trading AS offers trade in financial instruments and other investments. The company is based in Oslo, Norway. |
Finance/Rental/Leasing
|
Vistin Pharma AS
![]() Vistin Pharma AS Pharmaceuticals: MajorHealth Technology Part of Vistin Pharma ASA, Vistin Pharma is a leading European metformin producer supplying to international pharmaceutical companies. The company is located in Norway. Metformin is a standard first-line treatment for type 2 diabetes. The Norwegian company believes in balancing business growth with environmental sustainability, social responsibility, and ethical business practices. |
Pharmaceuticals: Major
|
Sector
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
-6,87% | 93,21 mln. | |
+20,23% | 43,77 mld. | |
+30,16% | 22,83 mld. | |
+20,40% | 15,56 mld. | |
+18,66% | 14,34 mld. | |
+54,90% | 12,96 mld. | |
-0,05% | 6,79 mld. | |
-11,72% | 6,41 mld. | |
-8,87% | 5,73 mld. | |
+14,65% | 5,69 mld. |
- Beurs
- Aandelen
- Koers VISTN
- Onderneming Vistin Pharma ASA